Literature DB >> 24710930

Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine.

Shi-Chao Wei1, Su Dong1, Li-Jun Xu2, Chen-Yu Zhang1.   

Abstract

The intestinal absorption of berberine (Ber) and its structural modified compound 8-hydroxy dihydroberberine (Hdber) was compared, and their effects on the intestinal absorption of sugar by perfusion experiment were investigated in order to reveal the mechanism of low dose and high activity of Hdber in the treatment of hyperglycemia. The absorption of Hdber and Ber in rat small intestine was measured by in situ perfusion. High performance liquid chromatography (HPLC) was used to determine the concentrations of Hdber and Ber. In situ perfusion method was also used to study the effects of Hdber and Ber on sugar intestinal absorption. Glucose oxidase method and UV spectrophotometry were applied to examine the concentrations of glucose and sucrose in the perfusion fluid. The results showed that the absorption rate of Ber in the small intestine was lower than 10%, but that of Hdber was larger than 70%. Both Hdber and Ber inhibited the absorption of glucose and sucrose at the doses of 10 and 20 μg/mL. However, Hdber presented stronger activity than Ber (P<0.01). It is suggested that Hdber is absorbed easily in rat small intestine and that its inhibitory effect on the absorption of sugar is better than Ber.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24710930     DOI: 10.1007/s11596-014-1256-6

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  24 in total

1.  Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages.

Authors:  Tzong-Shyuan Lee; Ching-Chian Pan; Chien-Chung Peng; Yu Ru Kou; Chien-Yu Chen; Li-Chieh Ching; Tsung-Huang Tsai; Shu-Fen Chen; Ping-Chiang Lyu; Song-Kun Shyue
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

2.  Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.

Authors:  Zhe Cheng; Tao Pang; Min Gu; An-Hui Gao; Chuan-Ming Xie; Jing-Ya Li; Fa-Jun Nan; Jia Li
Journal:  Biochim Biophys Acta       Date:  2006-09-20

3.  [8-hydroxy-dihydroberberine ameliorated insulin resistance induced by high FFA and high glucose in 3T3-L1 adipocytes].

Authors:  Li-jun Xu; Fu-er Lu; Ping Yi; Zeng-si Wang; Shi-chao Wei; Guang Chen; Hui Dong; Xin Zou
Journal:  Yao Xue Xue Bao       Date:  2009-11

4.  Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study.

Authors:  Li Liu; Yun-Li Yu; Jian-Song Yang; Yang Li; Yao-Wu Liu; Yan Liang; Xiao-Dong Liu; Lin Xie; Guang-Ji Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-13       Impact factor: 3.000

5.  Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.

Authors:  Zhanguo Gao; Xiaoying Zhang; Aamir Zuberi; Daniel Hwang; Michael J Quon; Michael Lefevre; Jianping Ye
Journal:  Mol Endocrinol       Date:  2004-05-13

6.  The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption.

Authors:  Guo-Yu Pan; Zhi-Jiang Huang; Guang-Ji Wang; J Paul Fawcett; Xiao-Dong Liu; Xiao-Chen Zhao; Jian-Guo Sun; Yuan-Yuan Xie
Journal:  Planta Med       Date:  2003-07       Impact factor: 3.352

Review 7.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

8.  Efficacy of berberine in patients with type 2 diabetes mellitus.

Authors:  Jun Yin; Huili Xing; Jianping Ye
Journal:  Metabolism       Date:  2008-05       Impact factor: 8.694

9.  Transport and accumulation of 2-deoxy-D-glucose in wild-type and hexokinase-deficient cultured Chinese-hamster ovary (CHO) cells.

Authors:  P Faik; M Morgan; R J Naftalin; R J Rist
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

10.  Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins.

Authors:  R B Sack; J L Froehlich
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more
  1 in total

Review 1.  Effects of Berberine on the Gastrointestinal Microbiota.

Authors:  Lichao Zhang; Xiaoying Wu; Ruibing Yang; Fang Chen; Yao Liao; Zifeng Zhu; Zhongdao Wu; Xi Sun; Lifu Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-02-19       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.